Sentence: Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3 , randomized , controlled , BOLERO-2 trial .
Drug combination annotation:
[{'class': 'POS', 'spans': ['everolimus', 'exemestane'], 'is_context_needed': True}]